Effect of recombinant human granulocyte-macrophage colony-stimulating factor (rh GM-CSF) in patients with lymphoid malignancies receiving unpurged or mafosfamide-purged autografts

Behring Inst Mitt. 1991 Dec:(90):69-74.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Bone Marrow Purging*
  • Bone Marrow Transplantation*
  • Colony-Forming Units Assay
  • Cyclophosphamide / analogs & derivatives*
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Lymphoma, Non-Hodgkin / therapy*
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Recombinant Proteins / therapeutic use
  • Transplantation, Autologous

Substances

  • Recombinant Proteins
  • mafosfamide
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Cyclophosphamide